0001181431-13-000830.txt : 20130103 0001181431-13-000830.hdr.sgml : 20130103 20130103143840 ACCESSION NUMBER: 0001181431-13-000830 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130103 DATE AS OF CHANGE: 20130103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH TODD N CENTRAL INDEX KEY: 0001523672 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 13505953 MAIL ADDRESS: STREET 1: 1033 SKOKIE BOULEVARD STREET 2: SUITE 355 CITY: NORTHBROOK STATE: IL ZIP: 60062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HORIZON PHARMA, INC. CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272179987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 LAKE COOK ROAD STREET 2: SUITE 520 CITY: DEERFIELD STATE: IL ZIP: 60062 BUSINESS PHONE: 224-383-3000 MAIL ADDRESS: STREET 1: 520 LAKE COOK ROAD STREET 2: SUITE 520 CITY: DEERFIELD STATE: IL ZIP: 60062 4 1 rrd363760.xml X0306 4 2012-12-31 0 0001492426 HORIZON PHARMA, INC. HZNP 0001523672 SMITH TODD N C/O HORIZON PHARMA, INC. 520 LAKE COOK ROAD, SUITE 520 DEERFIELD IL 60015 0 1 0 0 EVP & Chief Commercial Officer Common Stock 2012-12-31 4 A 0 22500 0 A 29568 D Common stock 2013-01-02 4 S 0 6998 2.36 D 22570 D Employee stock options (right to buy) 2.40 2013-01-02 4 A 0 61000 0 A 2023-01-01 common stock 61000 61000 D Restricted stock units 2013-01-02 4 A 0 55000 0 A common stock 55000 55000 D On January 3, 2012, the reporting person was granted restricted stock units which vest upon the achievement of certain performance criteria. On December 31, 2012, 22,500 of these restricted stock units vested in connection with the achievement of certain of these performance related goals. No unvested restricted stock units with respect to this grant were outstanding after the completion of this transaction. Includes 3,719 shares of the Company's common stock acquired pursuant to an employee stock purchase program. Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations. The shares subject to the option vest and become exercisable in forty-eight equal monthly installments from the vesting commencement date of January 2, 2013. Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock. The restricted stock units vest in four equal annual installments beginning January 2, 2014. /s/ Robert J. De Vaere, Attorney-In-Fact 2013-01-03